drugset / Trial / NCT00020644

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

NCT00020644 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of gemcitabine given as a continuous infusion in treating patients who have advanced metastatic cancer.

Timeline

Start
2000-03
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — Intravenous